Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Reactive Lymphocyte Count Measurement

Known as: LYMRCT, Reactive Lymphocytes 
The determination of the number of reactive lymphocytes present in a blood sample.
National Institutes of Health

Related topics

Related topics

5 relations
Atypical Lymphocyte Count MeasurementAtypical lymphocyteCDISC SDTM Laboratory Test Terminology by CodeCDISC SDTM Laboratory Test Terminology by Name
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
Detection of lymphocytes that target tumor-specific mutant neoantigens—derived from products encoded by mutated genes in the… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2015
Review
2015
Adoptive cell transfer as personalized immunotherapy for human cancer
Adoptive cell therapy (ACT) is a highly personalized cancer therapy that involves administration to the cancer-bearing host of… Expand
Is this relevant?
Highly Cited
2006
Highly Cited
2006
A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer
Purpose: A phase I study was conducted to assess the safety of adoptive immunotherapy using gene-modified autologous T cells for… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma.
PURPOSE We investigated the combination of lymphodepleting chemotherapy followed by the adoptive transfer of autologous tumor… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
Regulatory T (Treg) cells mediate homeostatic peripheral tolerance by suppressing autoreactive T cells. Failure of host antitumor… Expand
  • figure 2
  • figure 3
  • figure 5
  • figure 6
Is this relevant?
Review
2004
Review
2004
Regulatory T cells and mechanisms of immune system control
The immune system evolved to protect the host against the attack of foreign, potentially pathogenic, microorganisms. It does so… Expand
  • table 1
  • figure 1
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma.
Although immunosuppression has long been recognized in Hodgkin lymphoma (HL), the underlying basis for the lack of an effective… Expand
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
Highly Cited
1999
Highly Cited
1999
High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy.
A majority of the human tumor-associated Ags characterized to date are derived from nonmutated "self"-proteins. Little is… Expand
Is this relevant?
Highly Cited
1991
Highly Cited
1991
Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens
THE long-standing hypothesis1,2 that tolerance to self antigens is mediated by either elimination3–8 or functional inactivation… Expand
Is this relevant?
Highly Cited
1990
Highly Cited
1990
Dendritic cells pulsed with protein antigens in vitro can prime antigen- specific, MHC-restricted T cells in situ [published erratum appears in J Exp Med 1990 Oct 1;172(4):1275]
T cells recognize peptides that are bound to MHC molecules on the surface of different types of antigen-presenting cells (APC… Expand
  • table 1
  • table 2
  • table 3
  • figure 2
  • figure 1
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE